How Patient Demographics, Imaging, and Beliefs Influence Tissue-Type Plasminogen Activator Use | Zendy

Michel Shamy | Zendy; Michael Pugliese | Zendy; Karl Meisel | Zendy; R Rodriguez | Zendy; Anthony Kim | Zendy; Frank W. Stahnisch | Zendy; Eric E. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

How Patient Demographics, Imaging, and Beliefs Influence Tissue-Type Plasminogen Activator Use

Author(s) -

Michel Shamy,

Michael Pugliese,

Karl Meisel,

R Rodriguez,

Anthony Kim,

Frank W. Stahnisch,

Eric E. Smith

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.013344

Subject(s) - medicine , perfusion scanning , thrombolysis , stroke (engine) , radiology , medical history , perfusion , clinical trial , surgery , mechanical engineering , myocardial infarction , engineering

Understanding physician decision making is increasingly recognized as an important topic of study, especially in stroke care. We sought to characterize the process of acute stroke decision making among neurologists in the United States and Canada from clinical and epistemological perspectives.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research